DeviceTalks
DeviceTalks by MassDevice
Subscribe
The DeviceTalks Weekly Podcast series delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies.
Available episodes
Newest first
Oldest first
6 days ago
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
First, a quick recap of DeviceTalks Boston. Then, a MedtronicTalks Podcast Replay, in which Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing suite of GI products including the AI-powered GI Genius and the swallowable PillCam. Chiang explains why he chose to couple the company’s broad platform with his own social media presence to reach more patients who may need treatment of gastrointestinal care. He also gives advice to other physicians who may want to amplify their own voices through social media.
playlist_add
May 6, 2022
DTW- What’s coming up at DeviceTalks Boston? A DTW contest! Also, can Fictiv fix the supply chain?
DeviceTalks Boston is here! Win a free registration.
In this week’s episode, we’ll give you a little taste of what you’ll see at the Boston Convention & Exhibition Center on May 10-11. Friend and colleague Steve Crowe, editorial director of the Healthcare Robotics Engineering Forum, will share what attendees will see at that meeting, which is co-located with DeviceTalks Boston.
Then, we’ll talk with Peter Stebbins about his Opening Keynote Interview with medtech veteran Peter Doyle, who is now dean of Harvard John A. Paulson School of Engineering and Applied Sciences.
We’ll also get a final update from Paul Grand, CEO of Medtech Innovator, about the 22 mid-stage medical device companies that will be presenting at DeviceTalks Boston. A selected few will then compete at Medtech Innovator’s Pitch Contest on May 11.
And to demonstrate we’re not just selling you on an event, we talk with Dave Evans, co-founder and CEO of Fictiv, a technology company that has raised nearly $200 million to fix – or disrupt – the supply chain.
Finally, a contest for loyal and attentive DeviceTalks Weekly Podcast listeners. Win free registration to DeviceTalks Boston!
playlist_add
Apr 29, 2022
DTW – How Baylis fits into Boston Scientific’s EP portfolio; also putting Medtech’s story to music
In this episode, Nick Spadea-Anello, Boston Scientific’s global president of electrophysiology, will explain how the $1.7 billion paid for Baylis Medical will help expand the Boston's extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant.
We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host.
Johnson, of course, brings his insider perspective to Newmarker’s Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech’s stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well.
Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston’s acquisition of Bayliss.
5 - https://www.massdevice.com/alcon-smartcataract-study-shows-enhanced-time-savings-during-cataract-surgery/
4- https://www.medicaldesignandoutsourcing.com/doj-subpoenas-philips-over-respironics-recall-ceo-addresses-investigation/
3 - https://www.massdevice.com/abbott-launches-upgraded-digital-health-app-for-neurostimulation/
More Abbott news today... https://www.massdevice.com/abbott-announces-u-s-launch-of-amplatzer-steerable-delivery-sheath-for-amulet-device/
2 - https://www.massdevice.com/ge-healthcare-medtronic-to-collaborate-on-improving-outpatient-care/
1 - https://www.massdevice.com/acutus-medical-sells-left-heart-access-portfolio-to-medtronic-in-50m-deal/
playlist_add
Apr 22, 2022
DTW - Hear how Shockwave and LimFlow are taking the fight to peripheral vascular diseases
In this episode, we’ll talk to two of the more innovative companies in the peripheral vascular space – Shockwave Medical and LimFlow – about how they’re helping to treat people who previously had few or zero options.
This episode is brought to you by Confluent Medical.
LimFlow CEO Dan Rose walked us through his decision to build his Medtech career in Europe. He also talked about LimFlow’s unique approach to using veins as a route to deliver blood to limbs rather than return blood to the heart.
Our second interview is with Doug Godshall, CEO and President of Shockwave Medical. Godshall admittedly came to medtech later in his career, but he’s taken on some of its most serious and intractable problems, first as CEO of HeartWare and now Shockwave Medical.
You can learn more about Shockwave here
https://shockwavemedical.com/about/our-story/
and LimFlow here.
https://limflow.com/
We’ll also have Chris Newmarker delivering his Newmarker’s Newsmakers including news from Philips, Johnson & Johnson MedTech, Natus Medical, Amazon Web Services, and Dentsplay Sirona.
Subscribe to this podcast on all major podcast apps.
#5 https://www.massdevice.com/philips-has-another-round-of-serious-ventilator-recalls/
#4 https://www.massdevice.com/johnson-johnson-medtech-is-shopping-for-ma-deals/
#3 https://www.massdevice.com/archimed-group-to-acquire-natus-medical-for-1-2b/
#2 https://www.medicaldesignandoutsourcing.com/amazon-web-services-aws-cloud-chief-medical-officer-taha-kass-hout-machine-learning-ai/
#1 https://www.massdevice.com/dentsply-sirona-sacks-ceo/
playlist_add
Apr 15, 2022
DTW -Vapotherm was going to have trouble meeting surging COVID-19 demands, then Viant stepped in
In this week’s episode, we interview Joe Army, CEO of Vapotherm, and Alton Shader, CEO of Viant. First. We’ll follow Army’s heartful move into Medtech, which includes his current role as CEO of Vapotherm, maker of the high flow nasal cannula that proved to be a highly effective tool to treat patients hospitalized with COVID-19. We’ll later learn that Vapotherm’s ability to supply hospitals with this life-saving technology was in doubt due to labor shortages. But Shader details how the contract manufacturer stepped in to immediately help with Vapotherm’s dilemma. The interview is a taste of the discussion Vapotherm and Viant will lead at DeviceTalks Boston on May 10. Go to devicetalks.com to register.
We also bring in former Johnson & Johnson executive Peter Stebbins to tell us about his upcoming interview with Frank Doyle III, dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Doyle will be our keynote interview subject on the morning of May 10 at DeviceTalks Boston.
Stebbins also provides his experience and insights to this week’s Newmarker’s Newsmakers including news from Medtronic, Masimo, Boston Scientific, GE Healthcare and FitBit.
#5 https://www.medicaldesignandoutsourcing.com/medtronics-ceo-would-like-to-put-the-tech-in-medtech/
#4 https://www.massdevice.com/masimo-completes-acquisition-of-sound-united/
#3 https://www.massdevice.com/boston-scientific-wins-fda-approval-for-imaged-guided-software-for-dbs-therapy/
#2 https://www.massdevice.com/ge-healthcare-elekta-collaborate-to-expand-precision-radiation-therapy-access/
#1 https://www.massdevice.com/fda-clears-fitbit-ppg-algorithm-to-detect-afib/
playlist_add
Apr 12, 2022
STRYKERTALKS - Acute Care’s Mathieson explains how Vocera fits into Stryker’s goal to help nurses
In this episode of StrykerTalks, Jessica Mathieson, vice president and general manager of the Acute Care, recounts her unusual path into the medical device industry, giving advice to others interested in making the transition. The conversation then delves into an unassuming – but critical – piece of medical equipment – the hospital bed where most patient-healthcare interaction takes place. Later in the interview, Mathieson will talk about Stryker’s work to provide new technologies that help healthcare workers handle their increasing stress loads; technologies that incorporate technology from the recently acquired Vocera. Also, how is Stryker sharing risk with hospitals to increase patient safety?
playlist_add
Apr 8, 2022
DTW - Think you know what Penumbra may look like in five years? CEO Elsesser’s vision might surprise
In this episode, Penumbra CEO Adam Elsesser shares why he left a successful law career to become CEO of a medical device startup. After selling that company to Boston Scientific, Elsesser and his co-founders started Penumbra, which has steadily built businesses in stroke and vascular businesses. But Penumbra’s biggest business may be an immersive VR technology system that’s able to improve mental health.
This episode is sponsored by TE Connectivity.
Executive Editor Chris Newmarker brings his top stories of the week. This episode’s Newmarker’s Newsmakers including Ascensia, Senseonics, GE Healthcare, Olympus, DJO, Abbott. We also highlight the biggest news of the quarter coming, including an acquisition by Medtronic.
Subscribe to this podcast on any major podcast player.
playlist_add
Apr 1, 2022
DTW - Endiatx embarks on fantastic voyage in microrobotics; Embecta CEO intros new diabetes player
In this episode, we’ll assemble the news team to bring you stories big, small and in the middle. Associate Editor Sean Whooley delivers HUGE results. He interviews CEO Dev Kurdikar and CFO Jake Elguicze, leaders of the newly spun out Embecta, the one-time business of Becton Dickinson that’s now an immediate player in the diabetes space. Later on, Jim Hammerand, managing editor of Medical Design & Outsourcing magazine, interviews Torrey Smith, the CEO and Co-founder of Endiatx, a small company developing microrobots that could someday replace the work of an endoscope. In between we’ll hear the Newmarker’s Newsmakers from Chris Newmarker, executive editor of life sciences. This week’s top stories including new from Philips, Biobeat, Staar Surgical, BD, Embecta and Owens Minor.
Find the articles here:
https://www.massdevice.com/government-warns-on-cybersecurity-issues-with-philips-e-alert-mri-monitoring-system/
https://www.massdevice.com/fda-clears-biobeats-remote-vital-sign-monitoring-system/
https://www.massdevice.com/staar-surgical-wins-fda-approval-for-evo-visian-implantable-collamer-lens/
https://www.massdevice.com/bd-completes-spinoff-of-embecta-diabetes-company/
https://www.massdevice.com/owens-minor-completes-1-6b-acquisition-of-apria/
To read Jim Hammerand's Medical Design and Outsourcing cover story on Endiatx go here. https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/
Subscribe on all major podcast apps.
playlist_add
Mar 29, 2022
IntuitiveTalks – How a new venture group keeps Intuitive’s eyes focused forward on the future
In this episode of IntuitiveTalks, we take our first look at Intuitive’s Future Forward program, a three-piece initiative to better understand how the company fits best into an evolving healthcare landscale. Our guests are Julian Nikolchev, an experienced medical device entrepreneur and investor who now serves as SVP, Development and Strategy at the Intuitive. Nikolchev led the creation of Intuitive Ventures, a $100 million corporate venture capital program led by our second guest, Oliver Keown, MD, a physician turned investor who is leading the creation of an intriguing portfolio of digital and medical device companies that will help inform Intuitive’s future. You can see Intuitive’s full team and portfolio here. https://ventures.intuitive.com/
playlist_add
Mar 25, 2022
DTWEEKLY - CEO Lebed explains how Ukraine-based CRO is keeping trials running during invasion
In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine, that works with pharmaceutical and medical device companies across the globe. In an interview from Lviv, Lebed says he was as shocked as many that Russia would invade its neighbor. The attack forced him to relocate with his family to Lviv, in the western part of the country. From there, he’s been able to lead the CRO as it keeps many clinical trials running. He calls the country’s regulators are “heroes” for vowing to process approvals while the capital city is bombed. He also says Pharmaxi is already planning for the future, which includes expanding operations into Poland and working within EU countries. You can find a way to donate to relief efforts for Ukraine here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine
playlist_add
Mar 18, 2022
DTWEEKLY! Why J&J and Medtech keep looking to the Cloud to power digital surgery and other platforms
In this episode, we talk to two principals of Johnson & Johnson MedTech’s push to bring higher powered tech into its digital surgery strategy.
In separate interviews, Johnson & Johnson Group CIO and Global VP of Medical Devices Larry Jones and Office of Digital Innovation Leader Peter Schulam (who also serves as global head of medical affairs, clinical affairs and pre-clinical research for Johnson & Johnson Medical Devices Cos.) explain how the company is moving toward the future.
In our Newmarker’s Newsmakers segment, Jim Hammerand, managing editor of Medical Design and Outsourcing, tells us about his ongoing Cloud series. We first heard from Jones and Schulam in an MDO article. Link below.
Jim also joins Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, in discussing medtech’s news of the week including news from robotic pill maker EndiaTx, Johnson & Johnson, Medtronic, DexCom and GE Healthcare and AliveCor.
Also, listen…
playlist_add
Mar 14, 2022
WELCOME TO STRYKERTALKS! Spencer Stiles on Wright, MAKO, and how tech fits into the future
In this debut episode of the StrykerTalks Podcast series, Spencer Stiles, group president of orthopaedics and spine business at the medical device giant, reveals the mixture of art and science that went into successfully integrating Wright Medical into Stryker’s industry leading orthopedic business. What does Wright’s portfolio and personnel bring to the table? We’ll also talk about MAKO’s future. How will robotic surgery fit into healthcare delivery more broadly, and what does new complementary tech make possible.
playlist_add
Mar 11, 2022
Medtronic’s Saba on how equity, inclusion lifts an organization; Tell your MedTech Innovator Story!
In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more welcoming – and better performing – workplace.
Paul Grand, CEO of MedTech Innovator, returns to take part in Executive Editor’s Chris Newmarker’s Newsmaker session. We talk about hour industry’s response to Russia’s invasion of Ukraine, Ryan Egeland, MD, joining Big Sky Innovator, the top-performing companies of 2021, the collapse of another SPAC deal, and an eye-opening approval.
https://www.medicaldesignandoutsourcing.com/how-medtech-and-pharma-are-responding-to-russias-invasion-of-ukraine/
https://www.massdevice.com/former-cardiovascular-systems-chief-medical-officer-joins-big-sky-biomedical-incubator/
https://www.massdevice.com/these-10-medtech-companies-stocks-performed-best-in-2021/
https://www.massdevice.com/memic-innovative-surgerys-spac-deal-is-off/
https://www.massdevice.com/alcon-launches-clareon-intra…
playlist_add
Mar 4, 2022
With the spin out over, CEO Jamali says ZimVie is ready to roll
In this week’s episode of the DeviceTalks Weekly Podcast, Vafa Jamali, CEO of the newest medical device company ZimVie, speaks with Chris Newmarker, executive editor at MassDevice, about the companys’ plans post-spinout from Zimmer Biomet. Jamali explains where the company sees opportunities to compete in the spinal space.
In addition to the interview, we talk about the medical device industry’s support of Ukraine, as it’s being invaded by Russia. If you want to support Ukrainians during this attack you can find some charities here.
https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine/
In our Newmarker’s Newsmaker’s segment we hit about news from Siemens Healthineers, Roche, Philips, Varian, Heartflow, and Butterfly Networks.
If you want to see the agenda for DeviceTalks Boston go here. https://boston.devicetalks.com/
If you want to register for my webinar discussing our plans for our in-person DeviceTalks Boston meeting go here. https://gateway.on24…
playlist_add
Feb 25, 2022
Philips' Heather Hudnut Page lays out the plan to build its image-guided therapy business
In this episode, we’ll speak with Heather Hudnut Page, vice president and general manager of peripheral vascular at Philips about the company’s ongoing efforts to build an image-guided therapy program. Hudnut Page will walk us through the four sizable acquisitions Philips has made to build out its pipeline.
We first visited Philips two years ago when we spoke with Chris Landon, Senior Vice President and Business Leader for Image-guided therapy devices. Chris Landon returns to the podcast to share his thoughts on this week’s Newsmarker’s Newsmakers.
This week, Executive Editor Chris Newmarker highlighted the news from Baxter, Shockwave, Smith & Nephew, Medtronic, and Abbott.
Subscribe to this podcast on any major podcast channel.
You can listen to Chris Landon's interview here. https://www.devicetalks.com/philips-imaged-guided-leader-landon-shares-global-giants-plans-for-minimally-invasive-devices/
playlist_add
Feb 18, 2022
Which of these finalist founders will be the winner of Medtech Color’s Pitch Competition!?
Welcome to the first ever DeviceTalks Weekly Pitchcast!
This week Kwame Ulmer, executive director of Medtech Color, sits in on the Newsmaker segment and delivers details on the upcoming Medtech Color Pitch Contest.
Then, you can hear from the contests finalists themselves -
AllergenIQ, bTECH LLC, Candlelit Therapy, Dialysis-X, Diatech Diabetes, Free From Marketplace, SealCath, Sunny and TAB Diagnostics.
You can watch the pitch competition on March 8 by registering at MedtechColor.org.
Chris Newmarker's Newsmakers includes Philips, Boston Scientific, Bayliss, Johnson & Johnson, DePuy Synthes and Masimo.
Subscribe to this podcast on every major podcast channel.
playlist_add
Feb 11, 2022
Diabetes Overview – Checking on promising tools from Dexcom, Bigfoot Biomedical and Senseonics
This week we’ll focus on a few of the exciting companies in the diabetes space.
Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval.
Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap.
Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about
the company’s Eversense 180-day CGM, which just received FDA approval.
Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical.
This episode was sponsored by Accumold.
Subscribe to this podcast on major podcast channels.
playlist_add
Feb 4, 2022
Distalmotion CEO Michael Friedrich sees huge opportunity for Dexter, a smaller laparoscopic robot
In this episode we’ll interview Michael Friedrich, CEO of Distalmotion, creator of Dexter, a robotic system used for laparoscopic procedures. Friedrich details how Dexter is positioned to build a market in an area untapped by other surgical robotic systems. The company recently closed on a $90 million Series E led by Revival Healthcare and 415 Capital. (For a related podcast listen to our most recent episode of Intuitive Talks on your DeviceTalks Weekly Library.)
Executive editor Chris Newsmaker delivers his Newsmaker’s Newsmakers – Boston Scientific, Medtronic, BD, Hologic and Senseonics. Find out how these companies are tied to the upcoming DeviceTalks Boston meeting and listen for the discount code.
Subscribe to this podcast!
playlist_add
Jan 28, 2022
BD’s Dave Hickey and Brooke Story on the diagnostics boom; Paul Grand brings Medtech Innovator news
We drill down on diagnostics – including COVID-19 testing – with Dave Hickey, newly promoted executive vice president and president of the life sciences segment of BD and Brooke Story, who took over his post as worldwide president of integrated diagnostic solutions. How did BD handle the crushing demand for at-home tests and where is diagnostics headed in the future.
Paul Grand, CEO of Medtech Innovator, sits in with Chris Newmarker and Tom Salemi on this week’s Newmarker’s Newsmakers. He also delivers some important deadlines for medical device startups.
This week's Newsmakers include Medtronic, Edwards Lifesciences, Distal Motion, Respironics and ZimVie.
Find out more about Medtech Innovator at MedtechInnovator.org. Register for DeviceTalks at devicetalks.com. Use the discount code mentioned in this episode!
Subscribe to this podcast on any major podcast channel.
playlist_add
Jan 27, 2022
How Intuitive’s ION could clear a pathway into the lung for better biopsies and treatments
In this episode, we learn about Intuitive’s OTHER ground-breaking robot, the ION endoluminal system. This episode is sponsored by Maxon Group.
ION allows for robot-assisted bronchoscopic procedures such as biopsies in the hardest to reach areas of the lung. The FDA cleared the ION system in 2019.
We speak with Charlie Dean, vice president and general manager of the endoluminal business unit at Intuitive, an engineer who has spent his career working to make smaller, more effective minimally invasive tools.
We also talk with Oliver Wagner, MD, vice president and medical officer of the endoluminal division. Wagner explains how his long-time pursuit of NOTES led him to join Intuitive. He also sees a future where ION can serve as a platform for many other devices.
Subscribe to this podcast on every major podcast platform.
playlist_add
Jan 21, 2022
Outset Medical’s Leslie Trigg explains how home-based dialysis can restore patients’ “sense of self”
In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices.
Drawing on past experiences, the CEO explains why she chose to lead Outset’s mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset’s “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches.
Chris Newmarker delivers another stellar Newmarker’s Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical.
Subscribe on all major podcast channels.
playlist_add
Jan 14, 2022
VELYS, INHANCE and other reasons why DePuy Synthes sees Ortho opportunities; 2021’s top DTW episodes
In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company’s growing portfolio.
First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market.
Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company’s VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry.
Instead of Newmarker’s Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We’ll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks.
Subscribe to all these podcasts at most major podcast platforms.
playlist_add
Jan 7, 2022
Hear how Olympus plans to become an even bigger player in the medical device industry
Happy New Year!
In this first episode of 2022, we’ll learn a lot about Olympus Corp.’s plans to expand into the medtech industry. The global behemoth has been doubling down on the industry in recent years.
COO Nacho Abia and Gabriela Kaynor, global division head of therapeutic solutions in the Americas, will lay out the plans to build into other parts of the medtech industry.
Chris Newmarker is back with his Newmarker’s Newsmakers! Chris will bring news from Boston Scientific, GE Healthcare, Titan Medical, Relievant Medsystems, Medtronic, Memic Innovative Surgery, and Stryker.
Subscribe to catch future episodes on any major podcast player.
playlist_add
Dec 17, 2021
Exploring HeartMate, CardioMEMS and the rest of Abbott’s toolbox to help heart failure patients
In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers.
This podcast is sponsored by KNF.
Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition.
Dr. Kormos also shares the most gratifying part of his job.
The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet.
Happy New Year!!! We'll see you in 2022.
LIKE! FOLLOW! SUBSCRIBE!
playlist_add
Dec 10, 2021
Recor, Medtronic share the state of Renal Denervation. Can Alva Health reduce the danger of strokes?
In this episode we’ll explore potentially life-saving treatments for hypertension and stroke.
First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program.
Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney.
We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system.
Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer.
Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic.
Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, expla…
playlist_add
Dec 6, 2021
How Intuitive’s surgical robots collect the data that can help improve surgical performance
In this episode, we learn about the data collecting during surgical robotic systems. Chief Digital Officer Brian Miller and Tony Jarc, Director, Research and Data Science , detail the importance of data being collected by Intuitive’s surgical robotic systems and how the company uses the data to help guide surgeons in the future.
playlist_add
Dec 3, 2021
Lobo and Pierce talk Wright, cool tech, robotics and the not-so-secret plans to keep Stryker growing
In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day.
In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging.
Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product.
In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific.
We also talk about pie.
playlist_add
Nov 24, 2021
Thank you. Thank you and thannnnk you.
Just a short message from Tom and Chris, two grateful guys who don't like pumpkin sausage.
playlist_add
Nov 19, 2021
DT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two years
This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.
This episode is sponsored by Medmarc.
The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness.
In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color.
Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA.
We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic.
Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for m…
playlist_add
Nov 12, 2021
TAVR-Talks Part II! Where does Abbott see opportunity? How does Medtronic view competition?
In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.
playlist_add
Nov 5, 2021
IntuitiveTalks – How Curet and Duncan make the surgical robot case to surgeons and hospitals
In the second episode of IntuitiveTalks, two senior executives explain how the company gets surgeons and hospitals to understand the benefits of the Da Vinci system.
EVP Dr. Myriam Curet, who describes herself as a late adopter of technology, shares why she opted to join Intuitive as CMO early on after trying the Da Vinci robot.
Similarly, SVP Gillian Duncan, who heads physician training and development, says her early experience with the robotic system convince her to leave her academic career to join the robotics pioneer.
Subscribe to this podcast on all major podcast applications.
playlist_add
Oct 29, 2021
NuVasive CEO Chris Barry positioning spinal pioneer for growth by embracing new digital technologies
This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual.
Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles.
Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive.
Subscribe to this podcast on all major podcast applications.
playlist_add
Oct 22, 2021
Surgical Robotics & Beyond - Hugo Scores CE Mark; Is Zimmer Biomet morphing into a tech company?
The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications.
Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry.
Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson.
Associate Editor Sean Whooley joins in on the fun.
Subscribe to this podcast on all major podcast applications.
playlist_add
Oct 15, 2021
Boston Scientific and Zenflow are bringing critical new tools to help urologists treat patients
The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other critical treatments. In this week’s episode, we’ll speak with Meghan Scanlon, SVP and president, Urology and Pelvic Health at Boston Scientific about that company’s growing pipeline bolstered by the acquisition of Lumenis.
This episode was sponsored by KNF Neuberger.
We’ll also connect with the leaders of Zenflow – CEO Nick Damiano and President Susan Stimson – about the start-up’s minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH).
Finally, we have all-hands (or most hands) on deck for this episodes Newmarker's Newsmakers. Jim Hammerand, managing editor of Medical Design and Outsourcing, talks about Koya Medi…
playlist_add
Oct 8, 2021
CEO Gary Guthart explains how Intuitive grew into the dominant force in surgical robotics
In this first episode of the new IntuitiveTalks Podcast, we’ll start right at the beginning. CEO Gary S. Guthart recalls how a court side basketball conversation led to his introduction to the early form of a surgical robot and convinced him to join. He also shares his expectations for the surging surgical robotics field, including how the company will view emerging competition.
This episode is sponsored by Tegra Medical.
playlist_add
Oct 8, 2021
We interrupt this DeviceTalks Weekly podcast with breaking news about a new podcast!
Co-hosts Tom Salemi and Chris Newmarker announce the newest member of the DeviceTalks Podcast family - IntuitiveTalks!
playlist_add
Oct 1, 2021
Stereotaxis, Levita Magnetics make attractive cases for magnet-powered surgical robot systems
Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good.
You’ll hear from David Fischel, CEO of Stereotaxis, a 30-plus year old medtech that’s going through a quiet but deliberate reboot. Fischel says he took the company over because Stereotaxis’ magnetic robotic surgery system makes interventional surgery safer, an assertion supported by Daniel Cooper, MD, associate professor at Washington University School of Medicine. Stereotaxis appears to be on the cusp of something big.
Then, Alberto Rodriguez-Navarro, MD, tells us why he sold everything to move from his native Chile to move to Silicon Valley and start Levitra Magnetics. The company is anticipating FDA approval for its own robotic system that could help hospitals overcome staffing shortages during laparoscopic procedures.
We’ll also hear our sponsor Futek explain how its miniaturized sensors are advancing robotic surgery.
Chris Newmarker, execu…
playlist_add
Sep 24, 2021
Visit the Osso VR ortho OR with CEO Barad; DePuy’s Peters sees growth in shoulder, spine, sports med
This episode of the DeviceTalks Weekly Podcast draws from two realities
First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company’s new Inhance Shoulder system will help the company grab market share in the increasingly competitive space.
Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR’s virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance.
Chris Newmarker, executive editor of life sciences, identifies this week’s Newmarker’s Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis.
Subscribe to this podcast on all major channels!
playlist_add
Sep 17, 2021
How ResMed, Inspire Medical Woke Up Demand for Innovative Apnea Devices & Data
Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer.
This week, we’ll talk with two of the leaders in this increasingly competitive market.
First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines.
This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com.
Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses.
Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers inclu…
playlist_add
Sep 10, 2021
The Complete History of the Sapien TAVR – from PVT’s Emerging Idea to Edwards Lifesciences' Success
Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic valve replacement.
In this week’s episode, Stanton Rowe, the former CEO of PVT, will walk us through the early days of TAVR, including the enormous doubt the start-up faced as it developed the technology. He also explained how Edwards came to acquire the start-up, which had strong interest from Medtronic, Boston Scientific, and others.
Rowe, who is now CEO of the NXT Biomedical incubator, also offers some provocative thoughts on the origins of medtech innovation (and explains why he misses medical device conferences.)
Larry Wood, corporate vice president at Edwards Lifesciences, will explain why Edwards opted to pursue PVT rather than continue to develop its own TAVR technology.
He also explains why the clinical trial testing of the valve now known as Sapien was so difficult and how he rewrote the com…
playlist_add
Aug 27, 2021
How single-use endoscopes are taking root and are changing healthcare - Ambu, Boston Scientific
This week, DeviceTalks Weekly Podcast examines the single-use endoscope market.
We’ll hear from market leaders Ambu and Boston Scientific in a replay of interviews we conducted in September 2020. Guests include Ambu’s CEO Juan Jose Gonzalez and Stephen Block as well Boston Scientific’s Endoscopy executives Dr. Brian Dunkin, chief medical officer, and Unit President David Pierce.
You’re also invited to participate in a discussion led by TE Connectivity on Tuesday’s DeviceTalks Tuesday.
Chris Newmarker, executive editor of life sciences at MassDevice, presents this week’s top Newmarker’s Newsmakers – Abbott, Boston Scientific, Medtronic, Johnston & Johnson, Auris and Amazon.
Subscribe to this podcast on Amazon, Google, Apple, Spotify and other major apps.
playlist_add
Aug 20, 2021
Hear how pulse field ablation programs may revolutionize cardiac ablation treatment
New therapeutic approaches require fresh perspectives, and few perspectives were as fresh as Dr. Steven Mickelsen, the developer of a potentially paradigm shifting cardiac ablation treatment – pulse field ablation.
Dr. Mickelsen, a high school dropout turned musician, fell deep enough in love with electrophysiology to go back to school, obtain a medical degree, and put his inclination to tinker to work in developing a new type of ablation.
In this podcast we’ll walk down the path that led Dr. Mickelsen to create Farapulse, the early pioneer in this form of energy that now belongs to Boston Scientific. Dr. Mickelsen left the company a few years ago but he’s resumed his work helping Acutus Medical bring their technology to the market. He serves as that company’s chief translational science officer.
In our second talk, we connect with Dr. Kenneth Stein, senior vice president and CMO of Boston Scientific’s cardiac rhythm management business.
Dr. Stein allows us to pick up whe…
playlist_add
Aug 13, 2021
How Abbott and Cordis are working to change the interventional vascular business
Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline.
This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed.
Subscribe to this podcast on all major podcast applications!
playlist_add
Aug 6, 2021
Why Koya CEO Doraiswamy is tackling lymphedema; Follow Todd Brinton’s unlikely path to Edwards
This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.
playlist_add
Jul 30, 2021
What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul
This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone.
Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD.
Subscribe to this podcast on all major podcast apps.
playlist_add
Jul 23, 2021
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential.
Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation.
Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.
playlist_add
Jul 16, 2021
Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion
Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what?
We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history.
Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious
Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage.
Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care.
Subscribe to…
playlist_add
Jul 9, 2021
Leerink sees surge in home dialysis; Vensana, LRV detail deal in CardioDx start-up Cleerly Health
This week we’ll focus on investor insights.
First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business.
What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function?
Also, what does NeuroPace’s success mean for other medtech companies.
In a follow up to our interview with Dr. James Min, CEO of Cleerly Health, we talk with two venture investors in the early heart attack risk detection company.
Justin Klein, MD, of Vensana Capital walks us through the steps he took before leading the company’s recent $43 million Series B round.
Tripp Peake of LRV Health explains why the company interests his venture firm’s limited partner base.
This is an opportunity for entrepreneurs to better understand the venture capital due diligence process.
Chris Newmarker, executive…
playlist_add
Jun 25, 2021
Why Minnetronix made its own medical device. How Cleerly raised $43m to upend Cardiovascular Dx
In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million.
Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed.
Subscribe to this podcast today on all major podcast channels.
playlist_add
Jun 18, 2021
How Arboretum Venture' Walker learned early in her medtech career to not take "No" as an answer
Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.
playlist_add
Jun 11, 2021
Medtronic’s Martha Reviews Year One as CEO: Culture, HeartWare and Giving Meaning to Market Share
A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold.
In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments.
Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines.
Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.
playlist_add
Jun 4, 2021
Can S+N's Aria open up ASC ortho market? Wall Street’s take on Coyle’s departure, Medtronic’s HVAD
In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform.
The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s next for the ortho leader?
Meanwhile, Kaila Krum, managing director of Truist Securities, delivers insights on two major stories of the week – the decision by Mike Coyle to leave the CEO post at iRhythm and Medtronic’s decision to pull its Heartware HVAD off the shelves.
Those two stories topped this week’s Newmarker’s Newsmakers, which also include items featuring Abbott, Abiomed and the FDA.
Subscribe on Google, Amazon, Apple, Spotify, and other leading podcast channels.
playlist_add
May 28, 2021
Makower making medtech innovation bigger, stronger; Medtronic’s Ha speaking up for AAPI colleagues
This week we’ll explore innovation and social equity.
First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast
Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this interview, Makower shares his earliest inventions – kind of mind-blowing – and how his early work at Pfizer helped him create the innovation process used today by biodesign programs across the world, including Stanford Biodesign where Dr. Makower will take over as director this fall. This interview is essential for any individual or organization that wants to innovate.…
playlist_add
May 21, 2021
How Atricure built a big business in Afib; A deep look into Abbott's new coronary imaging platform
This week, the DeviceTalks Weekly Podcasts delivers some learning.
First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI.
Then, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets. Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat patients diagnosed with long-standing…
playlist_add
May 14, 2021
Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing
Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business.
He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the new spirit infused by CEO Michael Mahoney.
We also speak with Eric Kolodziej, corporate vice president and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA.
Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s New…
playlist_add
May 7, 2021
First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics
In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms.
Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration.
Chris Newmarker, executive editor of life sciences at MassDevice, delivers this week’s Newmarker’s Newsmakers including reports from Neuroelectrics, Medtronic, and Apple. Danielle Kirsh, senior editor, also updates listeners on her recent report on four catheter-based devices to watch for this year.
Also, an update from our underground medtech analyst – Barry the Groundhog.
Please subscribe on all major podcast channels - Amazon, Apple, Google, Spotify
playlist_add
Apr 30, 2021
Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?
Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?
In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business.
In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than doubled its production of ventilators in 2020. He also discusses recent FDA clearances for two lines of critical devices.
In our closing keynote, Dr. Nadine Hachach-Haram, CEO and founder of Proximie, says the start-up reached its 2023-24 projected size in just a few months as hospitals and medical device companies sought the ability to collect surgeons to the outside world.
Dr. Hachach-Haram, a reconstructive surgeon, gives a detailed account of how a growing shortage of surgeons convinced her to start a technology company.
She also shares how the technology ultimately restored the life of so…
playlist_add
Apr 23, 2021
CEO Mike Coyle sets a strong beat for iRhythm’s future; Introducing new member of podcast family
In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January.
Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum.
In this conversation, Coyle discusses
• How he came to join the Medtech industry.
• The potential for its ZIO cardiac monitoring technology
• How the company is dealing with a disappointing reimbursement
• How the company will pursue the large asymptomatic market
• What’s expected to come from the company’s partnership with Verily
We also introduce the newest member of our DeviceTalks Podcast family. Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes.
Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmarkersjne…
playlist_add
Apr 16, 2021
How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?
This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics.
Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies.
We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races.
Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future.
Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/
Chris Newmarker of MassDevice re…
playlist_add
Apr 9, 2021
Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey
In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a career in medtech. Herrera has founded two companies – Spinal Singularity and Habit Camera – to create devices that can improve and save the lives of people who need help the most. Herrera also explains how his military training is serving him so well in medtech and how the medical device industry would benefit from including more veterans in its workforce.
We’ll also hear from Kwame Ulmer, principal at Ulmer Ventures and a lecturer at UCLA Anderson’s School of Management, about an effort his helping to lead to update the landmark study compiled by Josh Makower in 2010. The study blasted a regulatory process that it called “unpredictable, inefficient and expensive.”
Its finding led to introspection and changes, according to Ulmer who served at the FDA at the time. Now Ulmer is working with UCLA leaders to update the study. He’…
playlist_add
Apr 2, 2021
Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology
This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses.
We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail.
First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision.
Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal.
And, of course, Chris Newmarker, executive editor of Mass Device, delivers this week’s Newmarker’s Newsmakers including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott.
Finally, don…
playlist_add
Mar 26, 2021
CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids
Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity.
In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the US and around the world.
He also shares what’s next for the company which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health.
While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including the loss of loved ones to COVID-19 and other diseases.
CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medi…
playlist_add
Mar 19, 2021
J&J’s McEvoy talks vaccines, digital surgery, and the power of innovation; Stryker’s Murray sees 3D
HAPPY BIG 5-0!!
This week’s is our 50th DeviceTalks Weekly Podcast, and we’re going to celebrate!
Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson, makes her DeviceTalks Weekly debut.
In this update, McEvoy delivers great insights on several areas of interest including:
• COVID-19’s impact on J&J in the past, and what changes may remain in the future.
• J&J’s far-ranging digital surgery portfolio could bolster many of its specialties.
• How the company uses its innovation network to accelerate development
• Why she’s bullish on the future of eye care.
• How the company will prepare for future challenges.
We also talk with Naomi Murray, Director of Advanced Operations-Additive Technology at Stryker about her almost predestined path to join the orthopedics leader.
She’ll be leading the March 23 discussion on Additive Manufacturing at DeviceTalks Tuesday. Register at DeviceTalks.com.
Colleague Lisa Eitel, executiv…
playlist_add
Mar 12, 2021
CEO Shacey Petrovic shares how Insulet is convincing people with diabetes to swap shots for `Pods
Shacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day.
In this interview, Petrovic explains why research wasn't for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot.
In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday's DeviceTalks Clubhouse series.
Finally, Chris Newmarker delivers the big news of the week involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.
playlist_add
Mar 5, 2021
Arrigato Mr. Surgical Roboto – Ferré, Usen and Fernando steer Medtech toward digital surgery
In the longest DeviceTalks Weekly Podcast ever created, the leaders of three digital surgery companies – two with robotic components – explain where their systems will fit into Medtech future.
Anthony Fernando, the CEO of newly names Asensus (formerly Transenterix) maps out the company’s future in delivering a better solution for laproscopic procedure.
Todd Usen – a veteran of big Medtech companies – explains why he swapped P&Ls for just the L’s of a start-up Active Surgical, which is building a surgical mapping tool that could help surgeons avoid deadly errors.
Finally, Maurice Ferre,’ founder of orthopedic pioneer MAKO Surgical, says Memix is positioned to grab the opportunity being missed by larger medtech companies building their own robotic systems. He also walks us through the dinner where Stryker CEO Kevin Lobo made an offer that MAKO did not refuse.
MassDevice Honcho Chris Newmarker delivers his Newmarker’s Newsmakers featuring stories from Medtronic, Hillro…
playlist_add
Feb 26, 2021
Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently
Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant overhaul of medtech’s largest player.
In our closing keynote conversation, Martha says the company is clearing minor COVID-19 bump and sees open road for the company to continue to grab share from competitors.
Martha details what products are gaining the most traction while also identifying those that still have some ground to gain.
We also discuss:
- When it may bring its renal denervation project to the FDA
- Why the surgical robotic Hugo system will be worth the wait (and why development has taken more than a decade)
- Whether or not Medtronic will collaborate more with private equity firms, early-stage incubators and maybe even SPACs?
- What will the company’s acquisition strategy look like in 2021. And why.
- Why the price-cutting for drug-eluting stents may represent an opportunity for Medtronic’s more innovative products.
Opening our episode is an important inter…
playlist_add
Feb 19, 2021
Tale of Two CEOs - How Tim Herbert led Inspire to an IPO; Where Rob Bodor wants to take Protolabs
Inspire Medical CEO Tim Herbert never set out to be a CEO.
Yet, he spun a promising #sleepapnea technology out of Medtronic. He then assembled a team that helps hard-to-treat apnea patients live healthier lives through better sleep.
Oh, and the electrical engineer turned startup-CEO took the medtech public in 2018.
Listen to this episode to hear how Inspire management worked with the FDA, payers and public investor to build a burgeoning neuromed giant.
We also talk to Rob Bodor, the incoming CEO at Protolabs. Bodor succeeds the highly successful Vicki Holt who built the manufacturing company into an acquisitive powerhouse. Bodor shares what's next for the company.
Co-costs Chris Newmarker, executive editor of life sciences at MassDevice, unveils this week's Newmarker's Newsmakers featuring news from Thermo Fisher Scientific, Mainstay Medical, Theranos, Butterfly Networks and Zimmer Biomet's Newco.
Subscribe today on your major podcast apps - Apple, Amazon, Spotify.
playlist_add
Feb 12, 2021
Dean Kamen eyeing 3D organs; Todd Pope talks clean air; Joe Mullings says Medtech’s time is now
Please lift this jam-packed episode with your legs, not your back.
*We'll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech.
*Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID
*Joe Mullings of the Mullings Group explains why now is the best time to be in the Medtech industry.
Chris Newmarker, executive editor of life sciences, delivers a murderers row of #newmarkersnewsmakers with Philips, Medtronic, iRyhthm, Canary Medical and Apollo Endosurgery.
To hear Dean Kamen's entire interview with my Design World colleague Paul Heney go here. It's free and outstanding! https://gateway.on24.com/wcc/eh/2927718/lp/2870030/engineering-robots-for-the-future
Thanks for subscribing!
playlist_add
Feb 5, 2021
Can Corza bust up Medtech’s surgical supply monopolies? Why Zimmer’s spin out is only the beginning
In this week’s episode learn how Greg Lucier, executive chairman of Corza Medical, intends to use his experience and GTCR's capital to build a surgical supply company that he says will challenge medtech's (almost) monopolies.
Corza's strategy rests upon customization, a high level of digitalization and customer service. Lucier also explains how working on the railroads led to his joining the medtech industry.
Chris Newmarker, executive editor of life science, interviews Rich Newitter, Managing Director, Medical Supplies and Devices, about Zimmer Biomet’s decision to spin off its dental and spinal business into a new company.
Newitter also explains how Zimmer Biomet is grabbing share in the orthopedic space and building an enviable portfolio of digital sensors and systems.
Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others.…
playlist_add
Jan 29, 2021
CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4
In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream.
Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the groups goals and invites entrepreneurs of color to apply for the group’s Pitch Contest.
The deadline is Feb. 5. Go to medtechcolor.org for more information.
Truist Security Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies.
Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again.
Pharma Editor Brian Buntz returns to the podcast to tell his story of his 10 days wearing a continuous glucose monitor from Dexcom.
Buntz wrote about the experience here, but h…
playlist_add
Jan 22, 2021
Where will Medtech innovation emerge in 2021? Hear from McCaney, Mejia and Morley
The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real. In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they're helping individuals and young companies work through the unique challenges of the time, including:
*Finding capital
*Working with corporates
*Understanding opportunities in a changing healthcare market
*Are there silver linings
Guests include
Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign
Jackie Mejia, PhD, director, gBeta Medtech
Scott Morley, director, office of economic partnerships, University of Pittsburgh
This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire presentation.
Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, NewmarkersNewsmakers. The big news belongs to DePuy, Philips,…
playlist_add
Jan 15, 2021
Digging into the Digital Medtech & Surgical Worlds with Mark Toland, Scott Huennekens, and Kal Patel
This week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD.
In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here. https://www.cnbc.com/2020/10/28/italy-symani-surgical-robotic-system-improves-microsurgery-procedures.html
Next, we talk with Scott “Go Go Go” Huennekens, employee number 1 at the former Verb Surgical, about the state of digital medtech. Huennekens, who previously led and sold Volcano Corp., explains why you can no longer have the latter without the former. Kal Patel, CEO of BrightInsight, explains why medtech must follow a different path – with equally unique challenges – to fully enjoy…
playlist_add
Jan 8, 2021
Medtronic’s Kowal on remote tech’s rebirth, SVB’s Norris delivers good news for VCs, CEOs
Dr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone.
Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising efforts, and their efforts were buoyed by surprising strong exiting opportunities through IPOs and M&A.
Co-hosts Chris Newmarker and Tom Salemi review the medtech industry’s response to the riot and occupation of the Capitol building. This week’s #NewmarkersNewsmakers includes news from Smith & Nephew, Stryker, and the disappearing Haven.
playlist_add
Dec 18, 2020
Taking the fight to COVID-19 - BD, DHL, Novant on delivering, shipping and administering the vaccine
Happy Vaccine Week!
This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most.
This week’s guests include
• Elizabeth Woody, Senior Vice President, Public Affairs at BD
• Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL
• Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health
Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020.
We also look ahead to 2021 offering our Big, Bold Predictions for the New Year. (And someone offers to pick up the first round of drinks at DeviceTalks Boston in October…well, sort of.)
This is the final episode of the DeviceTalks Weekly Podcast for 2020! Thanks to the tens of thousands (yep, really) people who have joined us on this audio journey.
We’ll be back in Jan…
playlist_add
Dec 11, 2020
Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020)
The past year of pandemic, social unrest and a divisive election - provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this difficult year.
His recipe for success is long, but it includes priorities, communication and listening.
Lobo also is serving his final year as chairman of AdvaMed. He shares how that experience gave him an even better appreciation of the medtech industry, which he says got treated unfairly at times but still came through with high grades.
Joining us for the first time as a co-host is Nancy Crotti, managing editor of Medical Design and Outsourcing. She’ll talk about the upcoming leadership issue.
Meanwhile, Sean Whooley, assistant editor of MassDevice, will share the five big news items of the week aka #NewmarkersNewsmakers. This week’s news comes from Quest, Pfizer, Boston Scientific and Medtronic.
And we'll learn which co-host had a…
playlist_add
Dec 3, 2020
Medtronic CEO Martha explains the why of competing, the reorg, and the importance of institutions
In this episode of the DeviceTalks Weekly Podcast, Medtronic CEO Geoff Martha brings us on the inside of Medtronic’s ongoing reorganization. Martha explains how the new company will be structured to work with outside vendors. (Hint: more autonomy, not total autonomy.)
He also explains why the company’s push to instill more competitive juice is aligned with its overarching mission of innovation.
Martha also discussed his long path to medtech and Medtronic. How he first met Omar Ishrak and why institutions like Medtronic and other medtech companies need to step up on a social scale.
This week, Dave Franchino, president of Delve, explains how the company is adapting innovation to fit the pandemic. (And suggests if you’re not finding opportunities to innovate, you’re simply not looking hard enough.)
But there is no DeviceTalks party without Chris Newmarker, executive editor of MassDevice, who shares this episode’s Newmarker Newsmakers. Companies covered include Medtronic, Vec…
playlist_add
Nov 20, 2020
Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA)
DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical.
This week we visit with…
Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might fits in this evolving political climate.
Spencer Stiles, group president of orthopaedic and spine at Stryker, who shares details on the Wright acquisition and the secret to the success of placing MAKO surgical robots in hospitals
Art Collins, senior advisor to Explorer Surgical. The former Chairman and CEO discusses leadership, Medtronic and the future for startups like Explorer.
Also co-host Chris Newmarker, executive editor of MassDevice, shares his selections for this week’s #newmarkersnewsmakers which includes news from BD, Boston Scientific and Johnson & Johnson.
playlist_add
Nov 13, 2020
Vizient, Truist on how COVID-19 has changed healthcare’s appetite for buying medical devices
This week’s DeviceTalks Weekly Podcast examines medtech’s readiness for the next COVID-19 surge.
Hospitals are ready, but their appetite for expensive medical devices has changed, forcing medtech companies to change how they sell or lose out entirely.
Justin Cassidy and Henry Soch of Vizient reveal why hospital executives are forced to divert funds away from new devices. They also explain how the power structure in capital purchases is shifting away from technology committees, creating a new challenge for medtech sales teams.
Kaila Krum, managing director of Truist Securities, explains how companies like Stryker, Zimmer Biomet and Globus are successfully putting units in hospitals. She confirms medtech companies are being forced to evolve the way they work with hospitals.
In the 2-minute-DeTalks, product development leader, podcast and president of Delve Dave Franchino joins us in a 2minute-detalks to explain how the company helps clients find the best solution to vexing proble…
playlist_add
Nov 6, 2020
Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand
In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical's Julian Nikolchev, senior vice president, corporate development and strategy and Oliver Keown, MD, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit into the robotic surgical company’s broader mandate to expand the profile of its product offerings? In our opening keynote, Neal Moat, MD, chief medical officer of Abbott’s structural heart business, talks about the success of the MitraClip and the impact COVID-19 is having on patients and Abbott personnel.
Chris Newmarker, executive editor of MassDevice, will roll out his Newmarker’s Newsmakers including news about Abbott, Masimo and Stryker. Sean Whooley, assistant editor, will also give an earning wrap on the show highlighting interesting reports from Inspire Medical, Hologic, Stryker and Coloplast.
DeviceTalks list…
playlist_add
Oct 30, 2020
Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar
In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical.
Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company.
In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?
Chris Newmarker, exe…
playlist_add
Oct 23, 2020
Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices
In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse.
In this conversation we’ll learn
-Why Landon left Medtronic
-Where Philips fits into medtech’s future
-How Philips hopes to expand
-Will Philips invest directly in start-ups?
-How did Covid-19 impact Philips?
We’ll also get Landon’s stance on pumpkin sausages. Disgusting or delicious?
We also welcome back Chris Newmarker, executive editor of Mass Device, who delivers his Newmarker's Newsmakers including news from GE Healthcare, Merit Medical, Pharma, Eurofins (Paris:ERF.PA) and DxTerity Diagnostics and the FDA
Subscribe today on your podcast apps!
playlist_add
Oct 16, 2020
Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?
In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical Design and Outsourcing, J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith & Nephew.
We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others.
Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivered with a rock solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.
playlist_add
Oct 9, 2020
Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy
In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages.
MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients.
Kiil will hit upon Smith + Nephew’s:
• CORI Robotics surgical tools
• Real Intelligence platform
• Interest in Ambulatory Surgery Centers
• Balance of OUS vs. US
• Future plans for extremities
INNOVATION AND FINANCE: Start-up Rhaeos took home this year’s Grand Prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went “all in” on develo…
playlist_add
Oct 2, 2020
Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity
In a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.
Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devicetalks-tuesdays-agenda/
In our opening interview, Ira Bahr, COO of AliveCor, explains how the company’s AI-enabled, consumer EKG device, KardiaMobile 6L, is connecting heart patient with their physicians. The company is selling the device for patient monitoring both in home and clinical trial settings. How will tech like this open t…
playlist_add
Sep 25, 2020
Can Boston Scientific Close the Gap in healthcare? Innovator Jeff Karp, MD, shares early challenges
Medtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity.
In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an industry need to do to bring equality to care. Go to knowyourhealth.com for more information.
In our first interview, Jeff Karp, MD, a prolific inventor and entrepreneur, shares his early challenges as a child when a learning difference limited his performance in school. After hearing some stern advice from teachers, Karp identified the problem…
playlist_add
Sep 18, 2020
Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees 5G future
INNOVATION & FINANCE: Is the traditional road show dead? Leslie Trigg, CEO of Outset Medical, fresh off taking the renal care company public, says despite initially grieving her inability to meet investors in person, she agrees that Zoom meetings gave her all the insights she needed to stage a successful IPO. In fact, she says the video calls might have even engendered a deeper understanding between executives and investors. Trigg also explains how Outset came to broaden its overall mission to create an enterprise system for dialysis.
NEW TOOLS & TECHNOLOGY: The doctor will see you now … from 3,000 miles away. Doug Teany, COO of Corindus Vascular Robotics, says the company’s Corpath interventional robotic system will save lives and money by shortening the distance between critical patients and capable care. Using the emerging 5G network, Corindus is moving toward a future where interventionalists can treat patients in different area codes, time zones and countries. The company is…
playlist_add
Sep 11, 2020
Ambu, Boston Scientific in the first single-use DeviceTalks Weekly– No sterilization necessary
MANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and President MedSurg. After a slow start due to COVID-19 shutdowns, Boston Scientific is putting the pedal to the metal by leveraging its extensive reach and might. Executives from both companies share why they can't see the ceiling to the potential of this technology.
MassDevice's Executive Editor Chris Newmarker will reveal this week’s #N…
playlist_add
Sep 4, 2020
Raising capital during Covid with Karen Long; Gail Daubert on CMS changes, Are linked pigs scary?
Our line up in Episode 25 of the DeviceTalks Weekly Podcast
INNOVATION & FINANCE – Managing Partner Karen Long says COVID-19 isn’t slowing down KCK Group, which closed on two major investments this summer. Long will be speaking on our first DeviceTalks Tuesday’s “Raising Capital in the Zoom Age.” Go to devicetalks.com.
REGULATORY & REIMBURSEMENT – Gail Daubert, founding partner at 4Front Strategies walks us through the proposed CMS rule to pay for innovative breakthrough technologies. Daubert suggests industry leaders offer their feedback on the proposed rule. For information on submitting feed back go to https://www.federalregister.gov/documents/2020/09/01/2020-19289/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and
NEWMARKER’S NEWSMAKERS – Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers. Items involve Medtronic, IBM, Elon Musk, and CMS.
playlist_add
Aug 28, 2020
Truist’s Kaila Krum on Medtronic’s Q1, APVC’s Juan Pablo Mas details new investment in Exo
In this week’s DeviceTalks Weekly Podcast, Kaila Krum, managing director at Truist Securities, explains why Medtronic is talking tough about finding new growth. Can the medtech giant pull off CEO Geoff Martha’s pledge to `Go Big or Go Home.”
Juan-Pablo Mas, partner at Action Potential Venture Capital, lends insights on his group’s commitment to EXO (pronounced echo), a maker of a portable ultrasound imaging device that might have somewhat unforeseen therapeutic applications. He also shares his hopes for LatinxVC, a non-profit creating opportunities in venture capital.
Senior Editor Danielle Kirsh and Assistant Editor Sean Whooley pinch hit for Chris Newmarker. Kirsh lays out her plans for this year’s Women in Medtech issue and Whooley walks us through this week’s Top 5 stories (aka Newmarker’s Newsmakers.) Medtronic, Abbott, Boston Scientific, Pelvital, and iRhythm all make the list. But who is number 1?
playlist_add
Aug 21, 2020
Can Fractyl Labs and Cala Health go where only drugs have gone before?
In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes.
In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success and how the start-up is working through COVID-19.
Finally, Chris and Tom hint at an upcoming event for the DTW community.
playlist_add
Aug 14, 2020
Vizient on PPE, Vicarious on VR-aided robotics and let's all hope for pumpernickel
DeviceTalks Weekly: Ep. 22 – This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical.
Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He'll also reveal when the company expects to see US hospitals running at pre-Covid levels. Hint, it'll be a while.
Adam Sachs, CEO of Vicarious Surgical, tells us how the company will put a new round of capital from high-powered investors to work in developing to develop a surgical system employing robotic and virtual reality technologies. How does the start-up expect to compete with the established leaders in the robotics space?
Co-host Chris Newmarker, executive editor, life sciences, will walk us through the five biggest newsmakers on the MassDevice site. Number one may surprise you, but given the time, perhaps it shouldn’t.
playlist_add
Aug 7, 2020
Ten ways medtech companies are finding their footing during the pandemic
Ten ways medtech is finding its footing during the pandemic
When COVID19 set upon the US in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day.
Over the past weeks, medtech executives from several leading companies reported back to analysts with a full quarter under their belt. To be sure, no one can claim to hold a full grasp on this crisis, but a survey of the calls reveals several observations worth pointing out .
In this podcast, we’ll list our Top 10.
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.
playlist_add
Jul 31, 2020
What in the world will Thrive Earlier Detection do with $257 million?
In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Isaac Kinde, MD, PhD, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up.
Chris Newmarker, executive editor of life sciences at MassDevice, also counts down on the biggest newsmakers in this week’s MassDevice.
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.
playlist_add
Jul 24, 2020
Can Drawbridge, Edwards bring disruptive innovation to blood drawing, heart surgery industries?
In this week’s podcast, we talk with Holly Logue, general counsel at Drawbridge Health, about the OneDraw, an innovative new tool that might upend the collecting, storage and testing of blood. Logue, a panelist in the upcoming DeviceTalks Tuesdays sponsored by Finnegan, will explain how her past work on Capitol Hill is helping this Silicon Valley company’s plans.
Meanwhile, we speak with Daveen Chopra, corporate vice president of surgical structural heart at Edwards Lifesciences, about that company’s commitment to treating the most serious cardiac patients. The company recently won FDA approval for its Konect Resilia aortic valve conduit, a vital new tool in helping heart patients, including many requiring emergency story.
Co-costs Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences at MassDevice, review the five biggest news stories of the week. We'll talk about Abbott, Becton Dickinson, Boston Scientific, Edwards Lifesciences,…
playlist_add
Jul 17, 2020
Is Medtech finally ready to capitalize on the promise of connectivity?
For years, medtech companies have known connectivity was good for them, but the promise of data streaming through devices didn't match the reality. COVID-19 changed that, creating an opportunity for device companies with connectivity plans in place.
In this episode, we speak with Dr. David Hayes, CMO of Biotronik, about that companies success in connecting cardiology patients. Meanwhile, Bill Betten of S3 Connected Health explains what device companies must do to prepare for medtech's next age.
We also review the week's top news involving Medtronic, Johnson & Johnson, Abbott, Edwards, and Smith+Nephew
playlist_add
Jul 10, 2020
CVRx Nadim Yared on COVID-19, diversity and equality; Hyalex CEO Mira Sahney shares startup details
DeviceTalks Weekly: Ep. 17 –
In this week’s episode of DeviceTalks Weekly, we follow up with Nadim Yared, CEO of CVRx, the guest of last week’s episode, to catch up on how the medtech executives is managing during the pandemic.
Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society.
We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups; Hyalex was identified as a notable startup in the recent report in Medical Design and Outsourcing.
In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic.
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
Jul 3, 2020
CVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.
Nadim Yared, CEO of CVRx
This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure.
The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology.
In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point.
Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on when he secured a job at GE even before graduating college.
In this talk, Yared speaks to several issues including:
The power of confidence and the dangers of overconfidence when building a career.
-How he decided to take the job at CVRx (and why he didn’t initially want to talk about the job with a recruiter.)
-What CVRx learned from other successes and failures in renal de…
playlist_add
Jun 26, 2020
Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.
DeviceTalks Weekly: Ep. 15 – Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.
In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic.
We also unveil the 20 medical device companies you need to know.
https://www.medicaldesignandoutsourcing.com/20-medical-device-startups-you-need-to-know-2020/
Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.
We also visit with Heidi Dohse, Sr. Program Manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTa…
playlist_add
Jun 19, 2020
Stryker's Kevin Lobo, Dexcom's Kevin Sayer talk diversity, COVID-19; also more on Medtronic deal
This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients.
Kevin Lobo, chairman and CEO of Stryker, explains how his company – and the industry group AdvaMed – has been working to increase diversity of its workforce, particularly in senior and sales positions. Lobo is serving a two-year term as chairman of AdvaMed. In this interview, Lobo speaks specifically to how Stryker is tracking progress, where it has come up short, and how it’s working to help workers identify their own biases.
Lobo also says Stryker is poised to regain momentum after the pandemic.
Next, Kevin Sayer, executive chairman, CEO and president of Dexcom, says the company’s continuous glucose monitors are finding a home in hospitals as they help monitor the health of COVID-19 patients. Sayer says the company’s monitors have helped keep patients, especially diabetics, off ventilators and allowed them to…
playlist_add
Jun 12, 2020
Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup
DeviceTalks Weekly: Ep. 13 – Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup
In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health.
Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to [asking] was there a way we could create our own opportunities,” she said of her eight years as the corporate investor.
We ask Ryan about her move into medtech investing from investment banking as well as the “secret power” that helped her succeed as an investor and an executive.
We’ll also discuss the unique commercial strategy Cala is employing as it begins rolling out its Cala Tr…
playlist_add
May 29, 2020
DTW's Commencement Speaker- Todd Brinton, MD, Edwards Lifesciences on building a career in medtech
In this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President,
Advanced Technology and Chief Scientific Officer of Edwards Lifesciences. Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech. NOTE: This conversation was recorded in March, prior to the full impact of the COVID-19 pandemic.
playlist_add
May 22, 2020
Medtronic is buckling up and ready to buy
DeviceTalks Weekly: Ep. 11 – Medtronic is buckling up and ready to buy
In this week’s episode of DeviceTalks Weekly, we dip into Medtronic’s quarterly call to hear why company executives feel the medtech sector is already rebounding. The global giant also intends to start using its vast cash reserves to bolster its bottomline through M&A.
We’ll also talk with Jeff Champagne of MPR about medtech’s need for speed. He’ll be leading a discussion on this subject and more on the upcoming DeviceTalks Tuesdays.
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
May 15, 2020
How do medtech investors, CEOS manage portfolio companies going forward?
DeviceTalks Weekly: Ep. 10 – How do medtech investors, CEOS manage portfolio companies going forward?
In this week’s episode of DeviceTalks Weekly, we talk with two successful starters of medtech companies about how they’re building and maintaining their medtech portfolios during this pandemic landscape.
Our guests this week are…
• Justin Klein, MD, managing partner, Vensana Capital
• Duke Rohlen, chairman, Ajax Health
Together, Klein and Rohlen have created, backed and sold medtech companies that have generated billions.
Klein, formerly of New Enterprise Associates, now co-manages his own venture firm, Vensana Capital. He previously served on the board of directors of Cartiva (acquired), ChromaCode, CV Ingenuity (acquired), EPIX Therapeutics (acquired), FIRE1, GPB Scientific, Intact Vascular, Metavention, Personal Genome Diagnostics, PhaseBio Pharmaceuticals (IPO), Relievant Medsystems, Senseonics (IPO), Topera (acquired), Ulthera (acquired), Vertiflex (acquired), Ve…
playlist_add
May 8, 2020
DeviceTalks Weekly: Ep. 9 – What’s the state of the Medtech job market?
In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term.
In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about…
• How bad is the current market?
• What’s the likelihood for recovery?
• What skills are in greater demand?
• What can people do to strengthen their hand?
Guests are:
• David L. Vied, global sector leader, Global Sector Leader, Medical Devices and Diagnostics, Korn Ferry
• Giovanni Lauricella, vice president, medtech practice-lead, The Mullings Group
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
May 1, 2020
AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 VC data
DeviceTalks Weekly: Ep. 8 – AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data
In this week’s episode of DeviceTalks Weekly, Scott Whitaker, CEO of AdvaMed, shares concerns he had over how the federal government would work with the medtech industry during the pandemic crisis. Does he feel the medtech industry was treated fairly? How does he see the federal government and medtech industry working together in the future? He answers those questions and more.
In our second interview, Jonathan Norris, managing director of Silicon Valley Bank, shares first-quarter data for medtech venture investments. The results might surprise you.
Guests are:
• Scott Whitaker, CEO, AdvaMed
• Jonathan Norris, managing director, Silicon Valley bank
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
Apr 25, 2020
DeviceTalks Weekly: Ep.7 – Edwards, Employment News, Update on Clinical Trials from Avania
In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive news from Baxter and Conformis, the hopeful projections from Edwards, and the cautionary tone from Medtronic.
We also interview Mark McIlduff, general manager, US, at the newly named CRO, Avania on the state of clinical trials. What changes might we expect in the future? Mark brings great insights.
Guests are:
• Mark McIlduff, general manager, US, Avania
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
Apr 20, 2020
DeviceTalks Weekly: Ep.6 – Hear about the Coventor, Q1 Earnings and MassDevice’s Medtech 100 Index
DeviceTalks Weekly: Ep.6 – Hear about the Coventor Ventilator, COVID-19 and Q1 Earnings and MassDevice’s Medtech 100 Index
In this week’s episode of DeviceTalks Weekly, Aaron Tucker of the Earl Bakken Medical Center shares the origin of the recently approved Coventor ventilator, which will be manufactured at-cost by Boston Scientific.
We’ll also hear Abbott CEO Robert Ford comments from the company’s Q1 analyst call as we begin to dissect how the COVID-19 pandemic will impact medtech earnings.
Finally, Danielle Kirsh, senior editor at WTWH Media, will share the origins of our new Medtech 100 Index, a powerful new tool for measuring how large medtech companies are managing in this new economy.
Guests are:
• Aaron Tucker, Lab Supervisor, University of Minnesota Earl E. Bakken Medical Device Center
• Danielle Kirsh, Senior Editor, WTWH Media
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
Apr 12, 2020
DeviceTalks Weekly: Ep.5 –What impact is COVID-19 having on start-ups?
DeviceTalks Weekly: Ep.5 –What impact is COVID-19 having on start-ups?
Raising capital for start-up is never easy. Try doing it during a pandemic.
In this week’s DeviceTalks Weekly, we’ll try to help entrepreneurs by talking with two guests who are committed to helping start-ups find the funding they need.
Paul Grand, founder and CEO of MedTech Innovator, explains how he’s working to keep start-ups connected to capital. His popular MedTech Innovator program is adapting to the times and creating new ways for start-ups to get in front of investors.
We’ll also talk with Shai Policker, CEO at MEDX Xcelerator, an incubator backed by Boston Scientific, Intellectual Ventures and others. Based in Israel, MEDX is moving forward and interested in investing capital in start-ups worldwide.
Co-host Chris Newmarker, executive editor, life sciences, for WTWH Media, also updates us on what articles are drawing the most interest on MassDevice and Medical Design and Outsourcing.
Don’t…
playlist_add
Apr 7, 2020
DeviceTalks DeviceTalks Weekly: Ep.4 –What does Medtronic's Puritan reveal mean for medtech?
DeviceTalks Weekly: Ep.4 –What does Medtronic's Puritan reveal mean for medtech?
Medtronic’s earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured?
In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and do not say. We’ll also get some legal insights on what strings are attached to the open source effort.
Guests are:
• D. Brian Kacedon, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
• Lee Teschler, Executive Editor, WTWH Media
• Scott Thielman, CTO, Product Creation Studio
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
playlist_add
Mar 27, 2020
DeviceTalks Weekly ep. 3 - Making Sense of Medtech's Regulatory Alphabet Soup
In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry.
Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than thrilled with the decision.
In our second conversation, Joy Sturm, procurement expert and partner at the DC office of Law Firm Hogan Lovells, walks us through the powers contained within the Defense Production Act invoked last week by the Trump administration.
Sturm, who brings 20-years of governmental purchasing experience to the conversation, answer several key questions including:
What CAN and CAN’T the government do under the act?
Which federal agencies are responsible for executing the DPA?
Can companies secure capital to pay for DPA-supported efforts?
What player is missing on the field in the battle against COVID-1…
playlist_add
Mar 20, 2020
DeviceTalks Weekly, Ep. 2 - Medtech goes to War
In this week’s DeviceTalks Weekly Podcast, hosts Tom Salemi and Chris Newmarker will detail medtech’s essential role in the escalating war against COVID-19. This week’s guests are Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executive will explain how their new FDA tools will aid against the diagnosis and treatment of COVID-19. We also ask them how the recently invoked Defense Production Act will impact medtech’s fight against the pandemic.
playlist_add
Mar 16, 2020
DeviceTalks Weekly, Episode 1, - Raj Denhoy, Jefferies
Welcome to the DeviceTalks Weekly Podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design and Outsourcing. This week, Chris Newmarker, Executive Editor, Life Sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, Editorial Director, DeviceTalks. Tom also chats with Raj Denhoy, Managing Director, Equity Research Analyst at Jefferies, who details how the Medtech sector is fairing in this unprecedented uncertainty. While most Medtechs stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he says there are safe havens out there and identifies one in the podcast. Finally, Tom and Chris explore what impact social distancing may have on medtech in the short-term – sales and deals - and long-term – innovation.
playlist_add
Aug 28, 2017
Intuitive Surgical CEO Gary Guthart plans to stay on top
Gary Guthart, the longtime CEO of Intuitive Surgical, tells MassDevice.com Executive Editor Brad Perriello why he's so confident about staying on top of the robot-assisted surgery heap, the company's five buckets for in-house R&D; and what he looks for in potential business partners.
playlist_add
Dec 30, 2016
Inside Google and Johnson & Johnson's bid to change surgery
DeviceTalks goes inside the union of two of the most innovative companies in the world, Google and Johnson and Johnson as they look to change the face of surgery. In this episode, we chat with Scott Huennekens, President and CEO, Verb Surgical, the robotic surgery platform spinout from Google and JNJ. Huennekens shares with us the mission of Verb, insights from his career in medical startups and why he thinks robots will be performing surgery in 50 years.
playlist_add
Nov 1, 2016
DeviceTalks Live: Being a woman in the corner office of medtech
There's an old saying that Ginger Rogers did everything Fred Astaire did but she did it backwards and in high heels. For Nancy Briefs, Deborah DiSanzo and Martha Shadan, it's also a challenge they know well. These CEOs and medtech veterans have made the journey from the ranks of the medtech industry to the corner office, making them, sadly, a rarity in this industry where just 1 out of 7 women in medicine hold senior executive positions. In this panel, recorded live at our DeviceTalks Boston event features remarks from DiSanzo, IBM Watson General Manager, Ms. Briefs, CEO, InfoBionic and Ms. Shadan, CEO, Rotation Medical.
playlist_add
Oct 18, 2016
The evolution of OCTANe and Orange County's technology ecosystem
Bill Carpou took over at OCTANe 18 months ago with the mission to increase Orange County, California's image as a technology super hub. Through programs like the Medical Device Investor Forum and a new emphasis on helping local companies stay in the area, OCTANe is one of the most innovative industry council's in the medical device space. We talked to Bill about OCTANe's upcoming event, as well as its recent merger with the Orange County Technology Alliance.
playlist_add
Oct 4, 2016
Changing the face of dialysis with NxStage Medical founder Jeff Burbank
Jeff Burbank started NxStage Medical in 1999 on the premise that patients with chronic kidney disease would benefit from bringing hemodialysis out of the clinic and into their homes. Now, 17 years later Burbank's hypothesis has been proven out and his Lawrence, Mass.-based company is topping more than $300 million in annual sales, while making a real difference in the lives of patients. In this interview, recorded at DeviceTalks Boston on September 28, 2016, we sit down with Jeff to discuss his business journey.
playlist_add
Sep 23, 2016
Does culture eat strategy for breakfast? A chat with Smiths Medical CEO Jeff McCaulley
When Jeffery McCaulley took the reigns at Smiths Medical, the company was in a slump. Several years of flat growth and a potential merger that didn’t go through, had sapped the winning spirit of the Twin Cities, Minn.- based company. However, with McCaulley’s arrival, came a renewed sense of what was possible for Smiths Medical. The medtech veteran employed several new initiatives, honed at companies like GE to rebuild the company’s culture and move it back on a path to growth. In this podcast, we discuss McCaulley’s playbook when it comes to fostering a winning culture in the medical device industry.
playlist_add
Jul 19, 2016
Teleflex CEO Benson Smith on what it takes to be great in sales
This interview, recorded live on June 6, 2016 in St. Paul, Minn. at DeviceTalks Minnesota, is one of the funniest, most enlightening and interesting discussions we've ever had at DeviceTalks. Teleflex CEO Benson Smith takes us through his career from door-to-door salesman to CEO of 1 of the top performing medical device companies in the past five years. Listen all the way to the end to hear an unforgettable tale of going all out to get the job.
playlist_add
Jun 28, 2016
Leading the battle against sepsis with Spectral Medical CEO Paul Walker
Dr. Paul Walker speaks to MassDevice about his efforts to take on endotoxins and sepsis at the head of Spectral Medical, his history with the deadly condition and what’s next for the burgeoning Canadian medical device firm.
playlist_add
May 6, 2016
How we built the company with Innovative Trauma Care's Joe Brennan
Innovative Trauma Care, a San Antonio, TX-based startup, has found a new way to stop the bleeding. The company's flagship product, the iTClamp is a hemorrhage control device for use in the extremities, scalp and neck. The device, which looks like a hair clip, seals the edges of a wound closed to stop further blood loss until the wound can be surgically repaired. We spoke to CEO Joe Brennan about the device and how it can help improve survival rates in trauma incidents.
playlist_add
Apr 21, 2016
Fighting the war on brain cancer with NovoCure chairman Bill Doyle
Novocure, the St. Helier, Jersey-based medical device company, which raised more than $158M in an IPO last year, is trying to change the way we fight cancer. Company officials say its proprietary tumor treating fields technology, marketed under the product name Optune, are a new tool in the war against some of the deadliest forms of cancer. MassDevice publisher Brian Johnson recently caught up with Doyle to discuss the technology, the company's origins and how its current concentration on glioblastoma is just the beginning.
playlist_add
Mar 22, 2016
How I built the company with Patrick Daly, CEO, Cohera Medical
Patrick Daly, CEO, Cohera Medical talks to MassDevice Executive Editor, Brad Perriello about starting up the absorbable surgical adhesives and sealants company, how he raised one of the largest seed rounds in history and why he's moving the company to Raleigh, NC. This episode was recorded on February 29, 2016 at DeviceTalks Raleigh.
playlist_add
Mar 7, 2016
What it's like to be the CEO of the world's largest medtech company with Bill Hawkins
On this episode of DeviceTalks we dive into life in the corner office with Bill Hawkins, former CEO of Medtronic and chairman of Immucor. Hawkins shares his experiences on the front lines of medicine where he has spent 25 years leading companies as diverse as start ups to the world's largest medical device company.
playlist_add
Dec 23, 2015
Talking innovation with Johnson & Johnson's medtech R&D guru Martin Fitchet
Martin Fitchet is responsible for R&D at JNJ's medical device unit, a tall task for anyone but appropriate for this former surgeon.
In this episode of DeviceTalks, we talk about what innovation means to a behemoth like JNJ and what areas he sees in medicine that are ripe for disruption.
playlist_add
Nov 18, 2015
A medtech veteran takes on C.diff: Rebiotix CEO Lee Jones
Clostridium difficile or C. diff. is a growing crisis in the U.S. with over 29,000 deaths and 500,000 cases annually, according to the CDC. The disease, which CDC officials warned can kill people in less than 30 days, is characterized by severe diarrhea, fever, and loss of appetite. Sadly, many elderly and infirmed patients are among the most vulnerable.
Roseville, Minn.-based Rebiotix is one of a handful of companies looking to harness the human microbiome into a treatment for recurrent C. diff, which impacts about 20-30% of patients, where there are currently no approved drugs to treat patients with two or more recurrences. Rebiotix is currently in Phase 2 clinical trials for the treatment, which harnesses gut microbiota and turns them into therapies. The company hopes recurrent C. diff is just the 1st in a pipeline of treatments than can be derived from the microbiome.
On this episode of DeviceTalks we discuss C.diff with Reviotix CEO Lee Jones. What personal stories led her to…
playlist_add
Nov 12, 2015
The leadership lessons of Stryker's John Brown
For a man who took a private company from $17 million in sales to a $4.5 billion publicly traded juggernaut, John Brown is a remarkably humble man. However, he is, by all intents and purposes, the man who put Stryker on the map. Today, the Kalamazoo, Mich.-based medical device company nets nearly $10 billion in annual sales.
In this episode of DeviceTalks, recorded at the recent AdvaMed 2015 conference, Brown spoke to us about how he built such impressive results during his tenure at Stryker, including the lessons he learned along the way.
playlist_add
Nov 12, 2015
Can Sirtex turn cancer into a chronic disease?
Big things sometimes come in small packages. For Sirtex Medical, the big thing comes in a really small package.
The Australian medical device company’s flagship product - the SIR-sphere - is made up of 30 to 60 million microspheres about the size of a grain of sand, which are injected into the hepatic artery and flow into the liver where they kill tumors from the inside.
In this episode of DeviceTalks, MassDevice.com publisher Brian Johnson talks with Mangano about the company, the learning curve he had of moving from a traditional medical device company to an oncology company and why the cancer market may be ripe for other medtech companies to enter.
playlist_add
Oct 27, 2015
Building the Cologuard and the fight against colorectal cancer with Exact Sciences Graham Lidgard
Colon cancer is one of the most preventable cancers, yet it is also one of the deadliest forms of the disease. In this episode, we speak with Graham Lidgard, the Chief Science Officer, Senior Vice President of Research and Development at Exact Sciences, a Wisc. -based company that has developed a non invasive test to detect colorectal cancer without having to undergo a colonoscopy. We talk to Graham about the Cologuard test and his 40 year career developing breakthrough medical technology.
playlist_add
Oct 15, 2015
Exit interview: Stephen Ubl moves on from AdvaMed
Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with us to reflect on his time as CEO of AdvaMed. In this episode of DeviceTalks, we go deep into Ubl's background, the fights over the medical device tax, forging a new partnership with the FDA and more.
playlist_add
Oct 13, 2015
Marie Johnson and the mission to prevent sudden heart attacks
Marie Johnson turned tragedy into a mission. In 2002, the CEO of Aum Cardiovascular lost her husband to a sudden heart attack, despite the fact that he was, by all accounts, a perfectly healthy man.
Fast forward 13 years and her company has commercialized a non-invasive test designed to quickly detect significant coronary stenosis called the CADence. Johnson hopes the pre FDA-approved device, which is on the market in Germany, will eliminate needless death due to coronary artery disease.
In this interview, recorded live at our DeviceTalks Minnesota event, touches on Johnson's incredible story.
playlist_add
Oct 13, 2015
One of medtech's most successful men reflects on failure
Dr. Manny Villafana is one of the most successful men in the history of medical innovation, having founded four companies, including CPI/Guidant Corp. and St. Jude Medical, Inc.
His most recent venture, Kips Bay Medical was supposed to be his best work yet. However, problems with the FDA and shortfalls on funding doomed the company, which shut down in September 2015.
Recorded live on September 23rd at DeviceTalks Minnesota, just one day after he resigned as CEO of Kips Bay Medical, we discuss failure with Dr. Villafana. How does someone who has had so much success deal with the opposite? What comes next for this serial entrepreneur?
playlist_add
Sep 25, 2015
The story behind Airing: One of medtech's most successful crowdfunding campaign
Stephen Marsh has more than 70 patents to his name but his most recent endeavor, the Airing device, may make him a household name. The Airing is a hoseless, maskless, disposable micro CPAP machine, which could one day change the game in sleep apnea. However, Marsh and company have already made quite the mark on medtech by running one of the most successful crowdfunding campaigns ever. The company has raised more than $1 million on Indiegogo, more than 10 times its initial goal.
In this episode of DeviceTalks, we talk to Marsh about the Airing device, inventing technology that sticks and how the company pulled off such a successful crowd funding campaign.
playlist_add
Sep 14, 2015
Spinal cord injuries and the quest to find a better treatment with Invivo Therapeutics Mark Perrin
Ten years after it was spun out of MIT, Invivo Thereapeutics and its neuro scaffold treatment for traumatic spinal cord injuries is moving closer to a reality. The company has completed enrollment of its 5 patient pilot study, which has made headlines around the world and is looking to push forward on adding more patients. In this episode of DeviceTalks, we talk to new CEO Mark Perrin about the company and why there has been so little movement in the fight against paralysis.
playlist_add
Sep 4, 2015
Behind the Boston Scientific turnaround with CEO Mike Mahoney
In this episode of DeviceTalks, recorded live at our DeviceTalks Boston event at Boston Scientific's corporate headquarters, we sit down with CEO Mike Mahoney to discuss the company's recent turnaround. Mahoney, who joined the company as its CEO in 2012, sat down with MassDevice's Brian Johnson to take us inside how the company has improved its performance.
playlist_add
Aug 28, 2015
Battling obesity with the alternative to bariatric surgery| ReShape Medical CEO Richard Thompson
Reshape Medical recently received FDA approval for its Duo balloon system for obesity. The company bills the device as an alternative to bariatric surgery for the majority of patients suffering from this global epidemic. In this episode we dig into the obesity epidemic and how ReShape Medical is looking to change the paradigm of care for patients needing to lose a significant amount of weight.
playlist_add
Aug 10, 2015
What makes Minnesota's medical alley tick with LifeScience Alley's Shaye Mandle
In this episode we catch up with LifeScience Alley CEO Shaye Mandle about doing business in Minnesota's world class medical device cluster. We delve into why the medical device and life sciences community clustered in the Twin Cities, what trends are developing in funding, m&a and technology in the area and, of course, where to go for a power breakfast in the area.
playlist_add
Aug 6, 2015
How teaching computers to recognize emotion led to healthcare innovation: MIT's Rosalind Picard
In this episode of DeviceTalks, we delve deeply into emotion and how teaching computers to recognize emotions led to a potentially major breakthrough in medical technology with MIT scientist and entrepreneur Rosalind Picard. Listen to hear the backstory behind her book Affective Computing, her work with artificial intelligence and pioneering wearable technology.
playlist_add
Jul 22, 2015
Changing the game with rotator cuff disease| A conversation with Martha Shadan
Rotation Medical is changing the game when it comes to treating rotator cuff disease, one of the most prevalent orthopedic conditions that people suffer from. We talk to CEO Martha Shadan about Rotation Medical's revolutionary biologic treatment and how the orthopedic world is changing.
playlist_add
Jul 13, 2015
Fighting depression with medical devices
Tal Medical's roots go back to a serendipitous discovery at McLean Hospital where patients suffering from bi-polar disorder reported feeling better after MRI. In this episode of DeviceTalks, Jan Skvarka, CEO, Tal Medical tells us about how that discovery could one day lead to a new clinical pathway for care for patients suffering from acute depression.
playlist_add
Jul 6, 2015
How I built the company with Merit Medical CEO Fred Lampropoulos | DeviceTalks
In this DeviceTalks podcast, we talk with Merit Medical founder and CEO Fred Lampropoulos about starting the Utah-based medical device company, his thoughts on leadership and his experience as a musician opening for The Doors and The Beach Boys.
playlist_add
Dec 15, 2014
How I built the company with Masimo CEO Joe Kiani
Medtech entrepreneur, patient safety advocate Joe Kiani, CEO, Masimo Corp. talks about building the company from scratch. In addition, he discusses his mission as the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West on November 19, 2014. Also featured, B. Braun CEO Carroll Neubauer.
playlist_add
Dec 2, 2014
Inside one of the largest medtech companies in the world| B. Braun Medical CEO Caroll Neubauer
MassDevice publisher Brian Johnson interviews Caroll Neubauer, CEO, B. Braun Medical about the medical device tax, Obamacare, patient safety and the current state of the medical device industry.
playlist_add
Nov 7, 2014
How we built the bionic eye with Second Sight's Robert Greenberg
One day, Second Sight Medical CEO Robert Greenberg, may be considered one of the most important figures in the fight against blindness.
On this episode of DeviceTalks, he discusses the journey to bring sight to the blind with the Argus II "Bionic Eye. "
playlist_add
Aug 5, 2014
What's the worst mistake you ever made? A discussion with medtech CEOs
Manny Villafanna, founder, St. Jude Medical, Guidant and Kip's Bay Medical, joins medtech CEOs Brian Concannon, Duane DeSisto, Charles Carignan and Carmichael Roberts for a discussion on leadership.
playlist_add
Aug 5, 2014
Inside the world of diabetes, bionic limbs and wearable sensors| A panel discussion
This CEO panel was recorded on July 15, 2014 at DeviceTalks Boston, hosted by MassDevice.com. It features CEOs from BIOM, Insulet and Carmichael Roberts, founder MC10, Arsenal Medical and 480 Biomedical.
playlist_add
Jul 22, 2014
How Haemonetics pioneered the blood collection world with Brian Concannon,
MassDevice publisher Brian Johnson interviews Haemonetics CEO Brian Concannon about the company's history, its present and the future of blood management and blood donation. The interview was recorded at DeviceTalks Boston on July 15, 2014.
playlist_add
Jun 30, 2014
How the Medtronic/Covidien merger will change medtech| A discussion
Panel discussion recorded at June 24th DeviceTalks Minnesota event featuring Nadim Yared, Deb Rectenwald, Philip Ebeling.
playlist_add
Jun 30, 2014
A look at the massive Medtronic/Covidien deal with Covidien exec Stacy Enxing Seng
This MassDevice podcast featuring Covidien's Stacy Enxing Seng was recorded live on June 24th at DeviceTalks Minnesota.
playlist_add
Nov 6, 2013
Managing diabetes with a smart phone with Glooko CEO Rick Altinger
Glooko CEO Rick Altinger and MassDevice's Brian Johnson discuss Glooko's mobile diabetes management app. Altinger describes the economics behind the Glooko platform, as well as the app's ability to foster easy communication between diabetes patients and healthcare providers.
playlist_add
Oct 11, 2013
How I built the company with CeQur CEO Jim Peterson
MassDevice’s Brian Johnson and CeQur's CEO Jim Peterson discuss Peterson’s personal connection to diabetes, and how that personal connection has impacted the company’s direction.
playlist_add
Jul 18, 2013
Making the deal with CEOs from Zoll, NxStage Medical, Ocular Therapeutix and ConforMIS
MassDevice reporter Brad Periello speaks with CEO and founder of NxStage Medical Jeff Burbank, Zoll CEO Richard Packer, ConforMIS CEO Philipp Lang, and Ocular Therapeutix CEO Amar Sawhney about what it takes to keep companies on the cutting edge, as well as their ups and downs as heads of major medtech companies.
playlist_add
Jul 18, 2013
Breaking the glass ceiling of medtech with Karen Licitra and Cathy Burzik
Johnson & Johnson's Global Medical Solutions Group Worldwide Chairman Karen Licitra talks about her role within Johnson & Johnson and how she thinks the economics of healthcare and the medical device industry need to change in order to accommodate the future.
playlist_add
Jul 18, 2013
Inside the $6.1 billion merger of Kinetic Concepts/Apax Partners with Catherine Burzik
Former Kinetic Concepts CEO Catherine Burzik takes you inside the $6.1 billion merger of Kinetic Concepts with Apax Partners in 2011, the largest leveraged buyout since the fall of Lehman Brothers.
playlist_add
Jun 27, 2013
What I've learned as CEO of Medtronic with Omar Ishrak
Medtronic CEO Omar Ishrak sat down with MassDevice's Brian Johnson to talk about his two years on the job at the Minneapolis-based medtech company. Ishrak shared his experiences, as well as the insights he has gained as Medtronic's CEO.
playlist_add
Jun 11, 2013
How I built the company with Semprus BioSciences CEO David Lucchino
Semprus BioSciences Corp. hopes to reduce the 60,000 deaths and $11 billion in costs related to "surface failures" of vascular catheters with its Sustain technology for coating medical devices.
playlist_add
Jun 11, 2013
Inside Medtronic with CEO William Hawkins
William Hawkins, former chairman and CEO of Medtronic Inc., dishes on mergers and acquisitions, the Food & Drug Administration and healthcare reform.
playlist_add
Jun 11, 2013
Medtech legend Thomas Fogarty on innovation, FDA and more
Dr. Thomas Fogarty, the founder of the Fogarty Institute for Innovation, discusses the investment climate for medical innovation, venture capital and explains why his passion for winemaking is actually an extension of his medical career.
playlist_add
Jun 11, 2013
Inside Capsule Tech with President Stuart Long
Capsule Tech's newly appointed North America president Stuart Long tells MassDevice about the company's surging growth and what it means to be a "middleware" service provider.
playlist_add
Jun 11, 2013
Inside Soteira with CEO Larry Jasinski
Soteira CEO Larry Jasinski talks to MassDevice about overcoming the odds with spinal fusion devices and managing a 510(k) win even after the FDA switched things up mid-stream.
playlist_add
Jun 11, 2013
Inside Covidien with CEO Joe Almeida
Covidien CEO Joe Almeida speaks at the MassDevice Big 100 Roundtable, July 11, 2011 about innovation, emerging markets and the worst mistake he's made in his professional career.
playlist_add
Jun 11, 2013
Making Lasik safer with Avedro CEO David Muller
Two decades after pioneering the technology that became Lasik, Avedro Inc. CEO David Muller is working to make the procedure safer and more effective.
playlist_add
Jun 11, 2013
Inside Neuronetics with President & CEO Bruce Shook
Neuronetics president & CEO Bruce Shook on treating an incurable psychiatric disorder, chasing reimbursement and turning psychiatrists into medical device proceduralists.
playlist_add
Jun 6, 2013
How we made an artificial nervous system with Alfred Mann Foundation CEO David Hankin
Alfred Mann Foundation CEO David Hankin tells MassDevice how to make an artificial nervous system using microstimulators that communicate wirelessly through the body.
playlist_add
Jun 6, 2013
Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem
After a stellar 2010, Michael Mussallem, CEO of Edwards Lifesciences Corp., is feeling bullish on transcatheter heart valves and the future of the Irvine, Calif.-based cardiac device maker.
playlist_add
Jun 6, 2013
Inside Abiomed and GI Dynamics with CEOs Mike Minogue and Stu Randle
Medical device company Abiomed's CEO Mike Minogue and Stu Randle, CEO of GI Dynamics, sit down with MassDevice.com editor Brad Perriello at the MassDevice Big 100 Roundtable East.
playlist_add
Jun 6, 2013
Why healthy patients die in the hospital with Johns Hopkins patient safety expert Peter Pronovost
Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.
playlist_add
Jun 3, 2013
Why Botox worked and the Lap-Band didn't with Allergan CEO David Pyott
Allergan CEO David Pyott speaks at the 2012 MassDevice Big 100 West about why the Irvine, Calif.-based medical aesthetics company is selling its Lap-Band business, why Botox is so popular and what the medical device industry can learn from the world of aesthetics.
playlist_add
May 30, 2013
Turning Boston Scientific around with CEO Mike Mahoney
Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East
playlist_add